Company Number: 13101823

Analysis Date: 2025-07-20 13:13 UTC

1. Credit Opinion: DECLINE
   Elevate Medica Ltd demonstrates a weakening financial position with net current liabilities of £244 as of 31 December 2024, down from net current assets of £544 the previous year. The company’s small scale (micro-entity) and minimal equity (£244) indicate very limited financial buffers. The declining working capital and net assets suggest deteriorating liquidity and solvency, increasing credit risk. Given the minimal fixed assets and low share capital (£1), the company lacks collateral for secured lending. Without evidence of improving financial performance or stronger cash flows, the risk profile is unfavorable for extending credit.

2. Financial Strength:
   The balance sheet shows total net liabilities of £244 at year-end 2024, a decline from net assets of £544 in 2023. Current liabilities (£4,861) slightly exceed current assets (£4,617), resulting in negative net current assets. The company holds no fixed assets and minimal equity, reflecting limited capital base and weak financial strength. The trend over the past two years is downward, with net assets eroding by over 50%. The business is likely under-capitalized to absorb shocks or fund growth.

3. Cash Flow Assessment:
   Current assets largely consist of cash or equivalents given the micro-entity status and no fixed assets disclosed. However, current liabilities slightly outstrip current assets, indicating potential short-term liquidity stress. The reduction in net working capital from £544 to negative £244 signals tighter operational cash flow and possible difficulties meeting short-term obligations promptly. The company’s reliance on a single director and limited employees may constrain operational scalability and cash generation.

4. Monitoring Points:

• Track quarterly cash flow and working capital trends to ensure ongoing liquidity.
• Review any changes in current liabilities and creditor payment terms.
• Monitor director’s reports or management commentary for plans to improve capitalization or profitability.
• Watch for any late filings or adverse changes in company status that could signal distress.
• Assess turnover and profit information (when available) to gauge operational performance improvement.